Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSLPE.L Regulatory News (SLPE)

  • There is currently no data for SLPE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Edison issues review on Standard Life Private

14 Mar 2019 11:31

RNS Number : 8871S
Standard Life Private Eqty Trst PLC
14 March 2019
 

 

London, UK, 13 March 2019

Edison issues review on Standard Life Private Equity Trust (SLPE)

Standard Life Private Equity Trust (SLPET) has broadened its opportunity set through the recent revision to its investment objective and policy, allowing it to make direct co-investments alongside private equity managers. While offering potential for improved returns, co-investments will only be introduced to the portfolio gradually and SLPET remains focused on maintaining a concentrated exposure to 'best in class' primary private equity fund opportunities, investing mainly in funds with a European focus. SLPET's NAV total return has outperformed the LPX Europe index NAV return over one, three, five and 10 years. The trust pays dividends quarterly and its 3.7% prospective yield is the second highest among the five dividend-paying funds in its private equity fund of funds peer group.

 

Having widened from 7.5% in November 2017 to 24.8% at 28 December 2018, SLPET's share price discount to NAV has narrowed in 2019. The current 14.9% discount is lower than its 17.0%, 17.4% and 18.3% averages over one, three and five years, respectively, and is one of the narrowest in its peer group. The board intends to increase the FY19 total annual dividend by over 3.0% by making four quarterly payments of 3.2p, representing a prospective yield of 3.7%.

Click here to view the full report.

 

All reports published by Edison are available to download free of charge from its website

www.edisoninvestmentresearch.com

About Edison: Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world-renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisers and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

For more information please contact Edison:

Gavin Wood, +44 (0)20 3681 2503

Sarah Godfrey, +44 (0)20 3681 2519

Investmenttrusts@edisongroup.com

 

Learn more at www.edisongroup.com and connect with Edison on:

LinkedIn https://www.linkedin.com/company/edison-investment-research 

Twitter www.twitter.com/Edison_Inv_Res 

YouTube www.youtube.com/edisonitv 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRASFWFSLFUSEED
Date   Source Headline
10th Apr 201410:41 amRNSHolding(s) in Company
2nd Apr 201410:07 amRNSDirector Declaration
1st Apr 201411:39 amRNSTotal Voting Rights
19th Mar 20147:00 amRNSQuarterly Trading Statement
3rd Mar 201410:00 amRNSTotal Voting Rights
3rd Feb 201412:20 pmRNSTransaction in Own Shares
3rd Feb 201410:58 amRNSTotal Voting Rights
29th Jan 20144:05 pmRNSTransaction in Own Shares
28th Jan 20142:29 pmRNSHolding(s) in Company
28th Jan 20142:27 pmRNSInterim Management Statement
28th Jan 20142:22 pmRNSResult of AGM
24th Jan 20144:41 pmRNSTransaction in Own Shares
2nd Jan 201412:01 pmRNSQuarterly Disclosure
2nd Jan 201411:59 amRNSTotal Voting Rights
31st Dec 20139:55 amRNSApplication for Listing
11th Dec 20134:51 pmRNSTransaction in Own Shares
4th Dec 20134:31 pmRNSAnnual Financial Report
28th Nov 20137:00 amRNSPreliminary Results
31st Oct 20132:40 pmRNSApplication for Listing
1st Oct 20139:57 amRNSQuarterly Disclosure
23rd Sep 201311:48 amRNSDirector Declaration
18th Sep 20137:00 amRNSQuarterly Trading Statement
1st Aug 20137:30 amRNSTotal Voting Rights
11th Jul 20136:14 pmRNSHolding(s) in Company
8th Jul 201312:28 pmRNSInterim Management Statement
1st Jul 201310:58 amRNSQuarterly Disclosure
28th Jun 201311:46 amRNSApplication for Listing
21st Jun 20139:47 amRNSDirector Declaration
11th Jun 20134:03 pmRNSDirectorate Change
3rd Jun 20131:58 pmRNSDirectorate Change
29th May 20135:00 pmRNSHalf Yearly Report
2nd Apr 201311:43 amRNSQuarterly Disclosure
2nd Apr 201311:40 amRNSTotal Voting Rights
26th Mar 20134:58 pmRNSTransaction in Own Shares
20th Mar 20134:05 pmRNSDirector/PDMR Shareholding
20th Mar 20137:00 amRNSQuarterly Trading Statement
18th Mar 20133:25 pmRNSHolding(s) in Company
8th Feb 20132:41 pmRNSDirector/PDMR Shareholding
5th Feb 20131:20 pmRNSDirector/PDMR Shareholding
1st Feb 201311:33 amRNSTotal Voting Rights
29th Jan 20134:37 pmRNSInterim Management Statement
29th Jan 20131:52 pmRNSIssue of Equity
29th Jan 20131:48 pmRNSResult of AGM
29th Jan 20131:47 pmRNSDirectorate Changes
9th Jan 20134:29 pmRNSScrip dividend reference price
4th Jan 201312:22 pmRNSQuarterly Disclosure
3rd Jan 201311:21 amRNSDirector/PDMR Shareholding
31st Dec 20128:00 amRNSApplication for Listing
31st Dec 20128:00 amRNSDebt Facility
14th Dec 201212:15 pmRNSDoc re. Annual Report and Circular

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.